Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mike Webb
AddedMar 31, 2024
UpdatedMay 31, 2026
Mike Webb

Mike Webb

Board Member, iQure Pharma

CrunchbaseLinkedIn

Mike Webb's Career

iQure Pharma
iQure Pharma

Wilmington, DE, US

Board Member· Board
DeuteRx
DeuteRx

Andover, MA, US

Board Member· Board
Tyrogenex
Tyrogenex

West Palm Beach, FL, US

Board Member· Board
Virtify
Virtify

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mike Webb's Career

iQure Pharma
iQure Pharma
Pre-Seed$1.9M62019Wilmington, DE, US
Board Member· Board

Leadership at iQure Pharma

Marcin MajewskiMarcin MajewskiCo-Founder
Pawel ZolnierczykPawel ZolnierczykCEO
Peter SchiemannPeter SchiemannBoard Member
DeuteRx
DeuteRx
Seed$2.8M52012Andover, MA, US
Board Member· Board

Leadership at DeuteRx

Dr. Sheila H. DeWitt PhDDr. Sheila H. DeWitt PhDBoard Member

Similar to DeuteRx

Lennham PharmaceuticalsLennham PharmaceuticalsConcord, MA, USPharmaceuticalsest. 2019Lennham PharmaceuticalsConcord, MA, US · est. 2019

Pharmaceutical firm leveraging deuterium chemistry for superior, patent-protected products.

Pre-Seed · $3.5M175
DemeRxDemeRxMiami, FL, USDrug Treatmentsest. 2010DemeRxMiami, FL, US · est. 2010

DemeRx, a Miami-based company, pioneers treatments for drug addiction in chronic pain patients since 2010.

Angel · $489.6k11
DekkunDekkunCambridge, MA, USPharmaceuticalsest. 2011DekkunCambridge, MA, US · est. 2011

Cambridge-based medical organization developing pharmaceutical technologies.

Series A · $10M30
DecisionRxDecisionRxDover, DE, USHealthcare Servicesest. 2022DecisionRxDover, DE, US · est. 2022

DecisionRx: Tech-enabled healthcare service optimizing prescriptions for improved patient outcomes.

Late Stage Private · $100M11
Tyrogenex
Tyrogenex
Acquired$21.4M02006West Palm Beach, FL, US
Board Member· Board

Leadership at Tyrogenex

Todd BradyTodd BradyBoard Member
Virtify
Virtify
Seed$25.1M752009Cambridge, MA, US
Board Member· Board

Leadership at Virtify

Satish TadikondaSatish TadikondaFounder
Bob ForlenzaBob ForlenzaBoard Member
Jeff WilliamsJeff WilliamsBoard Member

Similar to Virtify

Vibrant Commercial TechnologiesVibrant Commercial TechnologiesOwings Mills, MD, USCompliance Softwareest. 2006Vibrant Commercial TechnologiesOwings Mills, MD, US · est. 2006

Vibrant Commercial Technologies, Inc.: Providing compliance software and secure data solutions since 2006.

Series A · $6.8M30
KompliantKompliantBoise, ID, USCompliance Softwareest. 2020KompliantBoise, ID, US · est. 2020

Kompliant: Integrated, configurable compliance software for seamless lifecycle management.

Seed · $14M19
QuickComplyQuickComplyScotts Valley, CA, USCompliance Managementest. 2015QuickComplyScotts Valley, CA, US · est. 2015

QuickComply: A digital platform offering intuitive, customized business compliance management solutions.

Seed · $75k2
ViirtueViirtueSt. Petersburg, FL, USCloud Servicesest. 2013ViirtueSt. Petersburg, FL, US · est. 2013

Leading cloud services provider, serving over 60k subscribers across the US and Canada.

Series A · $10.8M75

Mike Webb's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Mike Webb

Victor LeeVictor LeeBoard Member · Ascent Solar TechnologiesSebastian GiordanoSebastian GiordanoBoard Member · Transportation and Logistics SystemsMichael WilsteadMichael WilsteadBoard Member · Infusion for HealthAndrew WynnAndrew WynnCo-Founder · AscendMatt BochnicekMatt BochnicekFounder · AscendexRaja KumarRaja KumarCo-Founder & CEO · UTI Ventures